Norges Bank’s Treace Medical Concepts TMCI Stock Holding History

Norges Bank’s Portfolio TMCI Stock Details TMCI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-65,800	Closed	-$490K	–	1848
2024 Q4	$490K	Sell	65,800 -302,200	-82%	-$2.02M	﹤0.01%	1794
2024 Q3	$2.13M	Hold	368,000	–	–	﹤0.01%	1653
2024 Q2	$2.45M	Hold	368,000	–	–	﹤0.01%	1686
2024 Q1	$4.8M	Sell	368,000 -316,278	-46%	-$4.22M	﹤0.01%	1626
2023 Q4	$8.72M	Sell	684,278 -189,414	-22%	-$1.91M	﹤0.01%	1534
2023 Q3	$11.5M	Hold	873,692	–	–	﹤0.01%	1422
2023 Q2	$22.3M	Sell	873,692 -132,300	-13%	-$3.41M	﹤0.01%	1209
2023 Q1	$25.3M	Buy	1,005,992 +540,463	+116%	+$12.7M	0.01%	1169
2022 Q4	$10.7M	Hold	465,529	–	–	﹤0.01%	1547
2022 Q3	$10.3M	Hold	465,529	–	–	﹤0.01%	1526
2022 Q2	$6.68M	Buy	+465,529	New	+$7.84M	﹤0.01%	1691
2022 Q1	–	Sell	-198,119	Closed	-$3.69M	–	2235
2021 Q4	$3.69M	Buy	+198,119	New	+$4.09M	﹤0.01%	1962

Other funds holding TMCI

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Norges Bank's TMCI Position: Q1 2025 in Review

Norges Bank sold out of Treace Medical Concepts (TMCI) in Q1 2025, closing a stake of 65,800 shares — an estimated $490K sold.

Norges Bank first reported a position in TMCI in Q4 2021 and held it in 12 quarters. The position peaked at $25.3M in Q1 2023. 138 funds tracked by Wall St. Rank hold TMCI as of Q1 2025.

Norges Bank reported no remaining Treace Medical Concepts position as of Q1 2025 after selling out during the quarter.
Norges Bank sold 65,800 Treace Medical Concepts shares in Q1 2025, an estimated $490K.
Norges Bank first reported a position in Treace Medical Concepts in Q4 2021 and held it in 12 quarters.
Norges Bank's Treace Medical Concepts position peaked at $25.3M in Q1 2023.
138 funds tracked by Wall St. Rank held Treace Medical Concepts as of Q1 2025.

Based on Norges Bank's 13F filing for Q1 2025, filed 13 May 2025.